International Manual of Oncology Practice | SpringerLink
Cancers | Free Full-Text | A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First-
PDF) 144PCyclin D1 differential activation and its prognostic impact among advanced breast cancer patients treated with trastuzumab
Lung Cancer in Greece - Journal of Thoracic Oncology
Table of Contents page: Journal of Thoracic Oncology
PDF) Excision Repair Cross Complementation Group 1 Immunohistochemical Expression Predicts Objective Response and Cancer-Specific Survival in Patients Treated by Cisplatin-Based Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell ...
PDF) Optimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapy
PDF) Intermittent Docetaxel Chemotherapy in Patients With Castrate-resistant Prostate Cancer | Christos Alamanis and Christos Papadimitriou - Academia.edu
Leprosy Reactivation and Lepromatous Gangrene Associated with Chemotherapy for Advanced Gastric Cancer: A Case Report and Review of the Literature - | Semantic Scholar
Lung Cancer in Greece - Journal of Thoracic Oncology
PDF) Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-κB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton
Table of Contents page: Journal of Thoracic Oncology
Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative
PDF) Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: A Hellenic Cooperative Oncology Group (HeCOG) study
Leprosy Reactivation and Lepromatous Gangrene Associated with Chemotherapy for Advanced Gastric Cancer: A Case Report and Review of the Literature - | Semantic Scholar
PDF) Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 ≥50% who progress on first-line immunotherapy: Real-world data from
Intermittent Docetaxel Chemotherapy in Patients With Castrate-resistant Prostate Cancer - Urology
PDF) REVIEW Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy
Table of Contents page: Journal of Thoracic Oncology
Table of Contents page: Journal of Thoracic Oncology
PDF) Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: The experience of the Hellenic
International Manual of Oncology Practice | SpringerLink
PDF) Bevacizumab in Ovarian Cancer
Table of Contents page: Journal of Thoracic Oncology
